Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Hany Elsaleh"'
Autor:
Gen Suzuki, Hideya Yamazaki, Norihiro Aibe, Koji Masui, Takuya Kimoto, Shinsuke Nagasawa, Shou Watanabe, Shou Seri, Akito Asato, Atsushi Shiozaki, Hitoshi Fujiwara, Hirotaka Konishi, Osamu Dohi, Takeshi Ishikawa, Hany Elsaleh, Kei Yamada
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Background Esophagectomy is the standard adjuvant treatment for superficial esophageal squamous cell carcinoma (SESCC) following noncurative endoscopic submucosal dissection (ESD). However, recent reports have also shown that ESD with adjuva
Externí odkaz:
https://doaj.org/article/f0fdee35e516437aba104ab61a33e317
Autor:
David A Simon Davis, Sahngeun Mun, Julianne M Smith, Dillon Hammill, Jessica Garrett, Katharine Gosling, Jason Price, Hany Elsaleh, Farhan M Syed, Ines I Atmosukarto, Benjamin J C Quah
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0264631 (2022)
Clinical adoption of immune checkpoint inhibitors in cancer management has highlighted the interconnection between carcinogenesis and the immune system. Immune cells are integral to the tumour microenvironment and can influence the outcome of therapi
Externí odkaz:
https://doaj.org/article/3da782be15d042aa81990887157ad50b
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0254018 (2021)
IntroductionIn locally advanced rectal cancer, longer delay to surgery after neoadjuvant radiotherapy increases the likelihood of histopathological tumour response. Chronomodulated radiotherapy in rectal cancer has recently been reported as a factor
Externí odkaz:
https://doaj.org/article/96dd169f25c34797a2611dcab2aeed7d
Autor:
Richard G. Pestell, Erik S. Knudsen, Evi Soutoglou, Min Wang, Olav Dahl, Hany Elsaleh, L. Andrew Shirley, Chenguang Wang, Xuanmao Jiao, Zhiping Li
Supplementary Methods, Figures 1-4 from Alternative Cyclin D1 Splice Forms Differentially Regulate the DNA Damage Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bb16bc814fc04093a4788bbd18d94cf
https://doi.org/10.1158/0008-5472.22387103
https://doi.org/10.1158/0008-5472.22387103
Autor:
David A. Simon Davis, Sahngeun Mun, Julianne M. Smith, Dillon Hammill, Jessica Garrett, Katharine Gosling, Jason Price, Hany Elsaleh, Farhan M. Syed, Ines I. Atmosukarto, Benjamin J. C. Quah
Publikováno v:
PloS one. 17(2)
Clinical adoption of immune checkpoint inhibitors in cancer management has highlighted the interconnection between carcinogenesis and the immune system. Immune cells are integral to the tumour microenvironment and can influence the outcome of therapi
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0254018 (2021)
PLoS ONE
PLoS ONE
Introduction In locally advanced rectal cancer, longer delay to surgery after neoadjuvant radiotherapy increases the likelihood of histopathological tumour response. Chronomodulated radiotherapy in rectal cancer has recently been reported as a factor
Autor:
Braden Higgs, Hany Elsaleh, Ellie Tsiamis, Siddhartha Baxi, Kim Moretti, Jeremy Millar, Paolo De Ieso, David Pryor, Marketa Skala, Tanya Holt, Susan E. Evans, Martin Borg, Jarad Martin, Farshad Foroudi
Publikováno v:
Radiotherapy and Oncology. 128:308-314
Background and purpose: Quality indicators (QIs) have been developed for many aspects of prostate cancer care, but are under-developed with regard to radiotherapy treatment. We aimed to develop a valid, relevant and feasible set of core QIs to measur
Autor:
Natallie Silliman, Suzanne Kosmider, Bert Volgestein, Desmond Yip, Hany Elsaleh, Madhu Sudan Singh, David Goldstein, Yuxuan Wang, Matthew Burge, Carolyn Bampton, Iain Skinner, Timothy J. Price, Christos S. Karapetis, Matthew Croxford, Jeanne Tie, Cristian Tomasetti, Ian T. Jones, Lu Li, Andrew Haydon, Rachel Wong, Michael Christie, David Rangiah, Joshua D. Cohen, Mary J Schaefer, Margaret Lee, Nickolas Papadopoulos, Peter Gibbs, Ben Tran, Kenneth W. Kinzler, Koen Simons, Jeanne Ptak, Isaac Kinde, Ian Faragher, Lisa Dobbyn
Publikováno v:
Flinders University PURE
ObjectiveFor patients with locally advanced rectal cancer (LARC), adjuvant chemotherapy selection following surgery remains a major clinical dilemma. Here, we investigated the ability of circulating tumour DNA (ctDNA) to improve risk stratification i
Autor:
Paul L. Schaefer, Xiyong Liu, Gerold Bepler, Jonathan L. Wong, Hany Elsaleh, Zhong Zheng, Raymond Lai, Yun Yen, Jennifer Moughan, Al B. Benson, William F. Regine, Chandan Guha, James J. Farrell, John S. Macdonald
Publikováno v:
Pancreas. 45:1485-1493
Objectives There is a need for validated predictive markers of gemcitabine response to guide precision medicine treatment in pancreatic cancer. We previously validated human equilibrative nucleoside transporter 1 as a predictive marker of gemcitabine
Autor:
N. Finn, G.G. Hanna, Jeremy Millar, Wee Loon Ong, L. te Marvelde, Roger L. Milne, G.A. Pitson, Hany Elsaleh, C. Hornby, Farshad Foroudi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e415